RAPT stock

RAPT Therapeutics Inc (RAPT) financials · $132.1M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

RAPT Therapeutics Inc (RAPT) $132.1M cap.

Cached annual income statement
LineFY2024FY2023
RevenueN/AN/A
Operating Income-$136.1M-$127.1M
Net Income-$129.9M-$116.8M
EPS (Diluted)-$3.19-$3.05
Cached annual balance sheet
LineFY2024FY2023
Total Assets$240.3M$173.3M
Current Assets$235.2M$161.8M
Cash & Equivalents$169.7M$47.5M
PP&E$1.37M$2.45M
Total Liabilities$50.4M$26.3M
Current Liabilities$48.4M$21.8M
Shareholders' Equity$189.9M$147.0M
Retained Earnings-$614.5M-$484.7M
Cached annual cash flow
LineFY2024FY2023
Operating Cash Flow-$83.3M-$97.0M
CapEx$122.0K$1.13M
Investing Cash Flow$52.7M$104.1M
Financing Cash Flow$152.9M$1.45M
Net Change in Cash$122.3M$8.53M
Free Cash Flow-$83.4M-$98.2M
These statements as JSON? API free 100/day

FAQ

What is RAPT P/E and revenue?

RAPT Therapeutics Inc (RAPT) $132.1M cap.

What is RAPT revenue?

RAPT income-statement cache has no revenue figure yet.

Is RAPT profitable?

RAPT Therapeutics Inc last cached net income is -$129.9M (FY2024).

What are RAPT total assets?

RAPT Therapeutics Inc last cached total assets are $240.3M (FY2024).

What is RAPT free cash flow?

RAPT Therapeutics Inc last cached free cash flow is -$83.4M (FY2024).

Not investment advice. Cached statements, not a live tape.